Dillon & Associates Inc. Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Dillon & Associates Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.8% in the 4th quarter, HoldingsChannel reports. The firm owned 31,836 shares of the medical equipment provider’s stock after purchasing an additional 3,362 shares during the period. Intuitive Surgical comprises approximately 2.3% of Dillon & Associates Inc.’s holdings, making the stock its 12th largest position. Dillon & Associates Inc.’s holdings in Intuitive Surgical were worth $18,019,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $25,000. Newbridge Financial Services Group Inc. boosted its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $27,000. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Caitlin John LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on ISRG shares. Truist Financial decreased their price target on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research note on Wednesday, April 15th. Leerink Partners decreased their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Bank of America decreased their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Finally, Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Monday, April 13th. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $579.33.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 105 shares of the stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 5,701 shares of company stock valued at $2,783,807. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $438.10 on Tuesday. The company’s 50 day simple moving average is $457.79 and its 200-day simple moving average is $509.66. The firm has a market capitalization of $155.16 billion, a PE ratio of 53.10, a P/E/G ratio of 3.50 and a beta of 1.51. Intuitive Surgical, Inc. has a 12 month low of $417.74 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.